BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12168808)

  • 1. The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis.
    Afuwape AO; Kiriakidis S; Paleolog EM
    Histol Histopathol; 2002; 17(3):961-72. PubMed ID: 12168808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis in rheumatoid arthritis.
    Paleolog EM
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S81-90. PubMed ID: 12110126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vasculature in rheumatoid arthritis: cause or consequence?
    Paleolog EM
    Int J Exp Pathol; 2009 Jun; 90(3):249-61. PubMed ID: 19563609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis.
    Nagashima M; Yoshino S; Ishiwata T; Asano G
    J Rheumatol; 1995 Sep; 22(9):1624-30. PubMed ID: 8523334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: critical involvement of the interaction with synovial fibroblasts.
    Kasama T; Shiozawa F; Kobayashi K; Yajima N; Hanyuda M; Takeuchi HT; Mori Y; Negishi M; Ide H; Adachi M
    Arthritis Rheum; 2001 Nov; 44(11):2512-24. PubMed ID: 11710707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.
    Koch AE; Harlow LA; Haines GK; Amento EP; Unemori EN; Wong WL; Pope RM; Ferrara N
    J Immunol; 1994 Apr; 152(8):4149-56. PubMed ID: 7511670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
    Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
    J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders.
    Ballara SC; Miotla JM; Paleolog EM
    Int J Exp Pathol; 1999 Oct; 80(5):235-50. PubMed ID: 10607014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts.
    Hitchon C; Wong K; Ma G; Reed J; Lyttle D; El-Gabalawy H
    Arthritis Rheum; 2002 Oct; 46(10):2587-97. PubMed ID: 12384916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis.
    Giatromanolaki A; Sivridis E; Maltezos E; Athanassou N; Papazoglou D; Gatter KC; Harris AL; Koukourakis MI
    Arthritis Res Ther; 2003; 5(4):R193-201. PubMed ID: 12823854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological, and pathological study in 12 patients monitored for 10 years.
    Latour F; Zabraniecki L; Dromer C; Brouchet A; Durroux R; FourniƩ B
    Joint Bone Spine; 2001 Dec; 68(6):493-8. PubMed ID: 11808986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of bizhongxiao decoction on the expression of VEGF in the synovial membrane of C II-induced rheumatoid arthritis in rats].
    Liang QH; He JH; Li XL
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):491-4. PubMed ID: 12658918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
    Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
    Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The application of vascular endothelial growth factor in forensic science].
    Li M; Liu M; Wang X; Liao ZG
    Fa Yi Xue Za Zhi; 2001 Nov; 17(4):239-41. PubMed ID: 12533875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
    Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
    Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis: a critical process in the pathogenesis of RA--a role for VEGF?
    Paleolog EM
    Br J Rheumatol; 1996 Oct; 35(10):917-9. PubMed ID: 8883427
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.